These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 20968152
1. Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions. Xiao W, Bian M, Ma L, Liu J, Chen Y, Yang B, Wu Q. Acta Cytol; 2010; 54(5):661-7. PubMed ID: 20968152 [Abstract] [Full Text] [Related]
2. [Detection of human papillomavirus L1 capsid protein expression in liquid-based cytology samples with abnormal cytology.]. Xiao W, Bian ML, Ma L, Liu J, Chen Y. Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):887-91. PubMed ID: 20193413 [Abstract] [Full Text] [Related]
3. [Clinical significance of HPV L1 capsid protein detection in cervical exfoliated cells in high-risk HPV positive women]. Wang J, Tian Q, Zhang S, Lyu L, Dong J, Lyu W. Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):253-7. PubMed ID: 26080935 [Abstract] [Full Text] [Related]
4. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology. Ki EY, Park JS, Lee A, Kim TJ, Jin HT, Seo YB, Gen Y, Park MY, Lee SJ. Int J Med Sci; 2019 Apr; 16(8):1096-1101. PubMed ID: 31523171 [Abstract] [Full Text] [Related]
5. Human papillomavirus DNA, HPV L1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression. Hu H, Zhao J, Yu W, Zhao J, Wang Z, Jin L, Yu Y, Han L, Wang L, Zhu H, Li F. Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110 [Abstract] [Full Text] [Related]
6. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology. Lee SJ, Lee AW, Kang CS, Park JS, Park DC, Ki EY, Lee KH, Yoon JH, Hur SY, Kim TJ. Int J Med Sci; 2014 Jan; 11(1):80-6. PubMed ID: 24396289 [Abstract] [Full Text] [Related]
8. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens. Yu L, Wang L, Zhong J, Chen S. Cancer Cytopathol; 2010 Feb 25; 118(1):47-55. PubMed ID: 20069634 [Abstract] [Full Text] [Related]
9. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management. Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, Seidman J, Roden RB. Mod Pathol; 2013 Feb 25; 26(2):268-74. PubMed ID: 22996373 [Abstract] [Full Text] [Related]
10. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS. Int J Med Sci; 2013 Feb 25; 10(12):1602-7. PubMed ID: 24151431 [Abstract] [Full Text] [Related]
11. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program. Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F. Acta Cytol; 2012 Feb 25; 56(5):506-14. PubMed ID: 23075891 [Abstract] [Full Text] [Related]
12. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results. Srodon M, Parry Dilworth H, Ronnett BM. Cancer; 2006 Feb 25; 108(1):32-8. PubMed ID: 16136595 [Abstract] [Full Text] [Related]
14. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study. Dane C, Batmaz G, Dane B, Cetin A. Ann Diagn Pathol; 2009 Apr 25; 13(2):73-7. PubMed ID: 19302953 [Abstract] [Full Text] [Related]
15. HPV L1 capsid protein expression in squamous intraepithelial lesions of cervix uteri and its relevance to disease outcome. Sarmadi S, Izadi-mood N, Pourlashkari M, Yarandi F, Sanii S. Arch Gynecol Obstet; 2012 Mar 25; 285(3):779-84. PubMed ID: 21789516 [Abstract] [Full Text] [Related]
16. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S. Oncol Rep; 2012 Jul 25; 28(1):346-52. PubMed ID: 22484610 [Abstract] [Full Text] [Related]
17. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K. Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920 [Abstract] [Full Text] [Related]
18. Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology. Shin EK, Lee SR, Kim MK, Kang EJ, Ju W, Lee SN, Han WS, Kim SC. Diagn Cytopathol; 2008 May 01; 36(5):311-6. PubMed ID: 18418881 [Abstract] [Full Text] [Related]
19. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I]. Wang R, Li X, Qian M, Niu J, You Z. Zhonghua Fu Chan Ke Za Zhi; 2015 Mar 01; 50(3):210-5. PubMed ID: 26268412 [Abstract] [Full Text] [Related]